# Drug-drug Interaction Study(CKD-501, Amlodipine)

> **NCT01341392** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 25 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** CKD-501
- **DRUG:** amlodiopine
- **DRUG:** CKD-501 amlodipine

## Key facts

- **NCT ID:** NCT01341392
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2011-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341392, "Drug-drug Interaction Study(CKD-501, Amlodipine)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01341392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*